Mitsubishi Chemical Group
Business Strategy Briefing 2026May 25, 2026
Manabu Chikumoto
President & Chief Executive Officer Mitsubishi Chemical Group Corporation
- FY25 Review
-
FY26 Outlook: From Defense to Offense
2
- FY26 Business Strategy
Agenda
-
FY25 Review
FY25 results
Final phase of structural reform
Foundations for growth beyond FY26
FY26 Outlook: From Defense to Offense
3
FY26 Business Strategy
Agenda
FY25 results: Group core operating income
FY25 results in the Chemicals business were challenging due to the recognition of an impairment loss on fixed assets related to Soarnol in the UK and deterioration in MMA monomer market conditions, but Industrial Gases remained solid, resulting in performance broadly in line with the previous fiscal year.
Continue to focus on accelerating growth in Specialty Materials and restructuring the materials business to deliver FY29 target
Mitsubishi Chemical Group
Core operating income (Oku yen)
Chemicals Industrial GasesChemicals
Industrial Gases
Core operating margin
10%Mitsubishi Chemical Group Core operating income margin230
2,120
4,600
Core operating margin
6%2,288
Core operating margin
2,360
2,250
1,479
427 243
-151
FY23*1
FY24*1
FY25
FY29 Target
Mitsubishi Chemical Group Corporation
*1 Adjusted by reclassifying Pharma as a discontinued business
FY25 results and FY26 forecast: Specialty MaterialsCore
operating
10%margin
In FY25, an impairment loss of approximately 30 billion yen was recognized following the review of the UK Soarnol investment plan. Specialty Materials*1 remained generally solid excluding this impact, reaching a level close to the forecast (65 billion yen*2).
In FY26, Specialty Materials*2 is expected to make steady progress in strengthening its revenue base and achieve business growth through the continued execution of three key initiatives, in addition to the results
achieved through the structural reform implemented over the past two years.
FY25 FY26
Specialty Materials
Core operating income
(Oku yen) *2
Core
Core operating margin
FY27-FY29
Key initiatives
Realization of investment effects
Impairment loss on Soarnol-related fixed assets in the U.K. (303)
Core operating income margin
Core operating margin
323
Absence of the impact of an impairment loss on Soarnol-related fixed assets in the U.K.
220
Core operating margin
3%operating margin
4%303
8%900
△157
305
Higher fixed costs and other factors
Contribution from
the "Three disciplined approaches in business operations"*5
1550
FY23
FY24
Contribution from
239
the "Three disciplined approaches in business operations"*5
74
449
FY25 FY25*4
FY26
FY29
Before organizational Structure change
After organizational structure change
Forecast*4
Target*4
*1 Advanced Films & Polymers, Advanced Solutions, Advanced Composite & Shapes
*2 Earnings forecast announced on October 31, 2025
*3 Films & Performance Materials, Composites & Shapes. Information Electronics, Polymer Compounds, Water & Infrastructure
Mitsubishi Chemical Group Corporation *4 Figures are presented based on reclassified reporting segment categories applicable from FY26 onward, in line with the organizational restructuring effective April 1, 2026.
*5 Excluding effects arising in the Corporate sector

